Tumour infiltration by TAMs was then evaluated on thyroid cancer sections by immunohistochemistry (IHC) for the macrophage markers IBA1 and for GALECTIN-3, this latter being described to regulate alternative macrophage activation towards an M2 pro-tumourigenic state [27,28,29]. The gene discussed is AIF1; the disease is neoplasm.